Recent Quarter Total Invested
$17.71 M
Recent Quarter Institutional Ownership Percentage
19.07%
Total Invested of Last Quarter
$24.23 M
Ownership Percentage of Last Quarter
16.99%
Citius Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 08/14/2024 | 10.16 M | $5.93 M | 100.00% | 6.38% |
VANGUARD GROUP INC | 08/13/2024 | 6.33 M | $3.69 M | -9.68% | 3.98% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 2.05 M | $1.20 M | 100.00% | 1.29% |
BLACKROCK INC. | 08/13/2024 | 1.81 M | $1.05 M | -79.31% | 1.14% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.65 M | $961,171 | -44.11% | 1.03% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.19 M | $692,595 | 1,256.30% | 0.75% |
NORTHERN TRUST CORP | 08/14/2024 | 1.06 M | $615,826 | -5.82% | 0.66% |
ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 932,333 | $544,066 | 0.00% | 0.59% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 640,539 | $373,882 | 5,607.38% | 0.40% |
STATE STREET CORP | 08/14/2024 | 581,797 | $339,595 | -73.67% | 0.37% |
Y-INTERCEPT (HONG KONG) LTD | 08/14/2024 | 389,469 | $227,333 | 100.00% | 0.24% |
JANE STREET GROUP, LLC | 08/15/2024 | 383,530 | $223,866 | 388.89% | 0.24% |
CENTIVA CAPITAL, LP | 08/14/2024 | 275,000 | $160,518 | 100.00% | 0.17% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 230,970 | $134,818 | 100.00% | 0.15% |
HIGHTOWER ADVISORS, LLC | 08/13/2024 | 215,020 | $126,000 | 2.46% | 0.14% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 09/16/2024 | 201,876 | $117,835 | 100.00% | 0.13% |
CITADEL ADVISORS LLC | 08/14/2024 | 185,614 | $108,343 | 100.00% | 0.12% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 159,422 | $92,943 | 205.44% | 0.10% |
INSPIRE ADVISORS, LLC | 08/08/2024 | 158,244 | $92,367 | 0.52% | 0.10% |
WEALTH ADVISORY SOLUTIONS, LLC | 07/26/2024 | 151,000 | $88,139 | 0.00% | 0.09% |
ARKADIOS WEALTH ADVISORS | 07/29/2024 | 150,000 | $87,555 | 50.00% | 0.09% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 09/16/2024 | 117,754 | $68,733 | 100.00% | 0.07% |
HRT FINANCIAL LP | 08/12/2024 | 100,099 | $58,000 | 100.00% | 0.06% |
BLAIR WILLIAM & CO/IL | 08/12/2024 | 96,200 | $56,152 | 0.00% | 0.06% |
KESTRA ADVISORY SERVICES, LLC | 08/14/2024 | 93,589 | $54,628 | 15.70% | 0.06% |
SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 77,600 | $45,295 | 100.00% | 0.05% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 76,073 | $44,404 | -78.69% | 0.05% |
HORST & GRABEN WEALTH MANAGEMENT LLC | 07/23/2024 | 75,722 | $44,199 | 0.00% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 68,334 | $39,887 | 100.00% | 0.04% |
UBS GROUP AG | 08/14/2024 | 62,779 | $36,663 | -53.36% | 0.04% |
LPL FINANCIAL LLC | 08/07/2024 | 61,485 | $35,889 | 5.13% | 0.04% |
MILLER INVESTMENT MANAGEMENT, LP | 08/13/2024 | 50,000 | $29,185 | 0.00% | 0.03% |
POINT72 (DIFC) LTD | 09/16/2024 | 49,820 | $29,080 | 100.00% | 0.03% |
PALOMA PARTNERS MANAGEMENT CO | 08/14/2024 | 47,554 | $27,757 | 100.00% | 0.03% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 43,521 | $25,416 | 431.20% | 0.03% |
PRIVATE ADVISOR GROUP, LLC | 08/05/2024 | 40,020 | $23,360 | 0.05% | 0.03% |
BARCLAYS PLC | 08/14/2024 | 37,817 | $22,000 | -59.97% | 0.02% |
RHUMBLINE ADVISERS | 08/01/2024 | 30,042 | $17,543 | -80.85% | 0.02% |
TCG ADVISORY SERVICES, LLC | 08/09/2024 | 30,000 | $17,511 | 0.00% | 0.02% |
JUMP FINANCIAL, LLC | 11/14/2024 | 28,431 | $16,595 | 100.00% | 0.02% |
BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 27,053 | $15,791 | 100.00% | 0.02% |
CITADEL ADVISORS LLC | 08/14/2024 | 24,700 | $14,417 | 100.00% | 0.02% |
GROUP ONE TRADING, L.P. | 08/14/2024 | 23,850 | $13,921 | 21.91% | 0.02% |
VICTORY CAPITAL MANAGEMENT INC | 08/05/2024 | 21,738 | $12,688 | 12.47% | 0.01% |
PROSHARE ADVISORS LLC | 08/13/2024 | 18,019 | $10,518 | -25.45% | 0.01% |
CITIGROUP INC | 08/12/2024 | 17,998 | $10,505 | -27.71% | 0.01% |
KEYNOTE FINANCIAL SERVICES LLC | 07/24/2024 | 17,500 | $10,215 | 0.00% | 0.01% |
HSBC HOLDINGS PLC | 08/12/2024 | 15,289 | $9,202 | 0.00% | 0.01% |
CSENGE ADVISORY GROUP | 07/10/2024 | 15,000 | $8,756 | 0.00% | 0.01% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 14,631 | $8,540 | -95.43% | 0.01% |
Citius Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CTXR shares?
During the previous two years, 57 institutional investors and hedge funds held shares of Citius Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Farther Finance Advisors, LLC: 0
Y-Intercept (Hong Kong) Ltd: 0
Schonfeld Strategic Advisors LLC: 0
ProShare Advisors LLC: 0
Point72 (DIFC) Ltd: 0
BALYASNY ASSET MANAGEMENT L.P.: 0
-
What percentage of Citius Pharmaceuticals, Inc. stock is owned by institutional investors?
19.07% of Citius Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CTXR ?
Institutional investors have bought a total of 9.30 M shares in the last 24 months. This purchase volume represents approximately $2.05 M in transactions.